The Role of Inflammatory Cytokines in the Tissue Injury of Leprosy

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 64, Issue 4 SUPPL., 1996, Pages

  Sarno, E N ^a   Sampaio, E P ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; HUMAN; IMMUNOPATHOGENESIS; LEPROSY; MYCOBACTERIUM LEPRAE; NERVE INJURY; REVERSAL REACTION;

COHORT STUDIES; CYTOKINES; HUMANS; LEPROSY; NEURITIS; RETROSPECTIVE STUDIES;

EID: 0030457663     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BARNES, P. F., CHATTERJEE, D., BRENNAN, P. J. and REA, T. H. Tumor necrosis factor production in patients with leprosy. Infect. Immun. 60 (1992) 1441-1446.
2. BECX-BLEUMINK, M. and BERHE, D. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int. J. Lepr 60 (1992) 173-184.
3. CASSATELA, M. A. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16 (1995) 21-26.
4. DESIKAN, P. and DESIKAN, K. Persistence of lepromatous granuloma in clinically cured cases of leprosy. Int. J. Lepr. 63 (1995) 417-421.
5. HERTLE, M. D., JONES, P. H., GROVES, R. W., HUDSON, D. L. and WATT, F. M. Integrin expression by human epidermal keratinocytes can be modulated by interferon- γ, transforming growth factor-β, tumour necrosis factor-α, and culture on a dermal equivalent. J. Invest. Dermatol. 104 (1995) 260-265.
6. KHANOLKAR-YOUNG, S., RAYMENT, N., BRICKELL, P. M., KATZ, D. R., VINAYAKUMAR, S., COLSTON, M. J. and LOCKWOOD, D. N. J. Tumour necrosis factor-alpha (TNF-a) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin. Exp. Immunol. 99 (1995) 196-202.
7. LAAL, S., BHUTANI, L. K. and NATH, I. Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythemal nodosum leprosum. Infect. Immun. 50 (1985) 887-892.
8. LIENHARDT, C. and FINE, P. E. M. Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation? Lepr. Rev. 65 (1994) 9-33.
9. LOCKWOOD, D. J., VINAYAKUMAR, S., STANLEY, J. N. A., MCADAM, K. P. W. J. and COLSTON, M. J. Clinical features and outcome of reversal (Type 1) reactions in Hyderabad, India. Int. J. Lepr. 61 (1993) 8-15.
10. 2 shows stable interindividual differences. Scand. J. Immunol. 27 (1988) 705-716.
11. MOREIRA, A. L., SAMPAIO, E. P., ZMUIDZINAS, A., FRINDT, P., SMITH, K. A. and KAPLAN, G. Thalidomide exerts its inhibitor activity on tumor necrosis factor α by enhancing mRNA degradation. J. Exp. Med. 177 (1993) 1675-1680.
12. PARIDA, S. K., GRAU, G. E., ZAHEER, S. A. and MUKHERJEE, R. Serum tumor necrosis factor and interleukin 1 in leprosy and during lepra reactions. Clin. Immunol. Immunopathol. 62 (1992) 23-27.
13. POCIOT, F., BRIANT, L., JOGENEEL, C. V., MOLVIG, J. WORSAAE, H., ABBAL, M., THOMSEN, M., NERUP, J. and CAMBON-THOMSEN, A. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol. 23 (1993) 224-231.
14. SAMPAIO, E. P., DUPPRE, N. C., NERY, J. A. C., MOREIRA, A. L. and SARNO, E. N. Development of giant reaction in response to PPD skin test in lepromatous leprosy patients. Int. J. Lepr. 61 (1993) 205-213.
15. SAMPAIO, E. P., KAPLAN, G., MIRANDA, A., NERY, J A. C., MIGUEL, C. P., VIANA, S. M. and SARNO, E. N. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J. Infect. Dis. 168 (1993) 408-414.
16. SAMPAIO, E. P., MOREIRA, A. L., SARNO, E. N., MALTA, A. M. and KAPLAN, G. Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J. Exp. Med. 175 (1992) 1729-1737.
17. SAMPAIO, E. P., SARNO, E. N., GALLILY, R., COHN, Z. A. and KAPLAN, G. Thalidonnide selectively inhibits tumor necrosis factor α production by stimulated human monocytes. J. Exp. Med. 173 (1991) 699-703.
18. SARNO, E. N., GRAU, G. E., VIEIRA., L. M. M. and NERY, J. A. C. Serum levels of tumour necrosis factor-alpha and interleukin-1β during leprosy reactional states. Clin. Exp. Immunol. 84 (1991) 103-108.
19. SARNO, E. N., NERY, J. A. C., GARCIA, C. C. and SAMPAIO, E. P. Is pentoxifylline a viable alternative in the treatment of ENL? Int. J. Lepr. 63 (1995) 570-571.
20. SCOLLARD, D. M., SMITH, T., BHOOPAT, L., THEETRANONT, C., RANGDAENG, S. and MORENS, D. M. Epidemiologic characteristics of leprosy reaction. Int. J. Lepr. 62 (1994) 559-567.
21. SELMAJ, K. W. and RAINE, C. S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23 (1988) 339-346.
22. SELMAJ, K. W., RAINE, C. S., CANELLA, B. and BROSNAN, C. F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87 (1991) 949-954.
23. SHARIEF, M. K., PHIL, M. and HENTGES, R. Association between tumor necrosis factor-a and disease progression in patients with multiple sclerosis. N. Eng. J. Med. 325 (1991) 467-472.
24. SRINIVASAN, H. Deformities and disabilities - unfinished agenda in leprosy work. Lepr. Rev. 66 (1995) 193-200.
25. VAN BRAKEL, W. H., KHAWAS, I. B. and LUCAS, S. B. Reactions in leprosy: an epidemiological study of 386 patients in west Nepal. Lepr. Rev. 65 (1994) 190-203.
26. WILT, S. G., MILWARD, E., ZHOU, J. M., NAGASATO, K., PATTON, H., RUSTEN, R., GRIFFIN, D. E., O'CONNOR, M. and DUBOIS-DALCQ, M. In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 encephalopathy. Ann. Neurol. 37 (1995) 381-394.